By Benben Song, Global Product Manager, Technical Services, Pall
The journey to commercialization for any therapeutic – whether small molecule or biopharmaceutical – has many twists and turns. And there are almost always challenges when it comes to simplifying and optimizing lab-scale processes to meet the more complex requirements of cGMP. For the new and rapidly evolving field of gene therapies, the road is even more complex, with very specific challenges. In some cases, developers may struggle to decide on the best equipment for the job and many others will not have extensive expertise in house.
The solution? Working with manufacturing partners that offer process development services. Choosing an experienced partner who understands the ins and outs of gene therapy can make a huge difference to the success of your project while helping you meet the needs of patients faster.